Paul Hastings Advises Lead Arrangers in US$1.435 Billion Financing of Concordia Healthcare Corp.

April 21, 2015

New York, NY -- Paul Hastings LLP, a leading global law firm, represented Royal Bank of Canada, Morgan Stanley Senior Funding, Inc., The Toronto-Dominion Bank and General Electric Capital Corporation as joint lead arrangers and joint bookrunners in a $700 million senior secured credit facility to finance Ontario-based Concordia Healthcare Corp.’s $1.2 billion acquisition of substantially all of the commercial assets of Cerberus-backed Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l. Concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs.

The firm also represented RBC Capital Markets LLC, Morgan Stanley & Co. LLC and TD Securities (USA) LLC as the initial purchasers in connection with Concordia’s Rule 144A / Reg. S offering of $735 million 7.000% senior notes due 2023, the proceeds of which also went to fund the acquisition.

Leveraged Finance partners Michael Baker and William Schwitter led the Paul Hastings team, which included Laurie Stein, Seth Chandler, Jason Ewart, Frank Grese, Katie Forer and Matthew Bartlett.

Paul Hastings is a leading global law firm with a strong presence throughout Asia, Europe, Latin America, and the United States. Through a collaborative approach, entrepreneurial spirit, and commitment to client service, the professionals of Paul Hastings deliver innovative solutions to many of the world’s top financial institutions and Fortune 500 companies.